Licaps® Drug Delivery System for Proof-of-Concept Clinical Study for an Innovative Gastro-Intestinal Disease Treatment

The purpose of the study was to characterize and encapsulate within 8 weeks a lipid based formulation in a Licaps® Drug Delivery System (Licaps® DDS) intended for a clinical trial to obtain Proof-of-Concept for an innovative treatment of gastro-intestinal diseases developed by Synergy Pharmaceuticals.

Download White Paper